CA Stock MarketDetailed Quotes

PAS Pascal Biosciences Inc

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Nov 26 09:30 ET
0Market Cap0.00P/E (TTM)

Pascal Biosciences Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
(Q2)May 31, 2022
(Q1)Feb 28, 2022
(FY)Nov 30, 2021
(Q4)Nov 30, 2021
(Q3)Aug 31, 2021
(Q2)May 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-69.71%-80.75K
75.98%-147.68K
60.89%-25.84K
71.81%-50.12K
87.50%-24.14K
73.25%-47.58K
28.73%-614.93K
39.50%-66.08K
19.46%-177.79K
-5.81%-193.16K
Net income from continuing operations
2.09%-132.63K
55.89%-480.28K
49.91%-201.45K
60.74%-94.73K
83.00%-48.63K
15.00%-135.46K
12.04%-1.09M
-21,214.04%-402.2K
24.83%-241.28K
30.84%-286.09K
Operating gains losses
---7.24K
---104.8K
---18.25K
--0
----
----
----
----
----
----
Depreciation and amortization
--0
-49.19%8.29K
-29.92%2.27K
-87.03%563
-61.39%2.73K
63.35%2.73K
30.83%16.33K
199.35%3.25K
-52.78%4.34K
543.13%7.07K
Asset impairment expenditure
----
155.26%129.48K
----
----
----
----
--50.72K
----
----
----
Remuneration paid in stock
-88.56%1.77K
-76.27%47.47K
-83.60%4.17K
-92.38%7.82K
-71.80%19.97K
1,245.01%15.51K
1,188.75%200.03K
1,642.88%25.45K
5,503.60%102.6K
1,687.63%70.83K
Other non cashItems
----
----
----
----
----
----
--46K
----
----
----
Change In working capital
-17.65%57.36K
56.69%252.15K
-72.51%57.93K
183.36%36.23K
487.74%88.34K
426.30%69.65K
-59.08%160.93K
517.53%210.7K
-157.23%-43.46K
-93.35%15.03K
-Change in receivables
-460.91%-3.83K
104.89%5.32K
100.41%559
-154.84%-5.31K
-85.18%10.75K
98.79%-683
-56.74%-108.93K
-78.49%-134.83K
47.49%9.68K
657.35%72.56K
-Change in prepaid assets
92.85%-988
-100.72%-53
50.20%6.29K
5.58%6.34K
118.51%1.14K
-509.15%-13.82K
-56.26%7.41K
-51.43%4.19K
-46.76%6.01K
-751.24%-6.16K
-Change in payables and accrued expense
-26.11%62.18K
-5.93%246.88K
-85.03%51.09K
159.50%35.19K
248.83%76.45K
166.18%84.15K
-41.13%262.45K
1,973.80%341.35K
-201.81%-59.14K
-121.76%-51.37K
Cash from discontinued investing activities
Operating cash flow
-69.71%-80.75K
75.98%-147.68K
60.89%-25.84K
71.81%-50.12K
87.50%-24.14K
73.25%-47.58K
28.73%-614.93K
39.50%-66.08K
19.46%-177.79K
-5.81%-193.16K
Investing cash flow
Cash flow from continuing investing activities
7.24K
8.98K
8.34K
0
0
0
Net PPE purchase and sale
--7.24K
--8.98K
--8.34K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--7.24K
--8.98K
--8.34K
----
----
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
25.90%75.54K
-75.19%154.84K
-64.72%8.96K
-26.41%40.96K
195.22%44.92K
-88.63%60K
32.48%624.08K
3,399.48%25.41K
-57.32%55.66K
-95.54%15.21K
Net issuance payments of debt
-5.57%75.54K
283.16%174.84K
-64.72%8.96K
717.50%40.96K
195.22%44.92K
--80K
-64.81%45.63K
--25.41K
--5.01K
--15.21K
Net common stock issuance
----
--0
--0
--0
----
----
82.91%624.5K
--0
---125.5K
-44.35%190K
Net other financing activities
----
56.57%-20K
--0
--0
--0
37.89%-20K
---46.05K
--0
--176.15K
---190K
Cash from discontinued financing activities
Financing cash flow
25.90%75.54K
-75.19%154.84K
-64.72%8.96K
-26.41%40.96K
195.22%44.92K
-88.63%60K
32.48%624.08K
3,399.48%25.41K
-57.32%55.66K
-95.54%15.21K
Net cash flow
Beginning cash position
207.87%8.37K
54.11%-7.76K
-66.07%16.91K
-83.59%25.44K
-98.67%4.66K
---7.76K
-104.51%-16.91K
-37.43%49.82K
-15.47%155.05K
3,053.45%349.91K
Current changes in cash
-83.57%2.04K
76.27%16.13K
79.01%-8.54K
93.01%-8.53K
111.68%20.78K
-96.45%12.42K
102.34%9.15K
63.02%-40.67K
-35.22%-122.13K
-212.02%-177.95K
End cash Position
123.22%10.41K
207.87%8.37K
207.87%8.37K
-66.07%16.91K
-83.59%25.44K
-98.67%4.66K
54.11%-7.76K
54.11%-7.76K
-37.43%49.82K
-15.47%155.05K
Free cash from
-69.71%-80.75K
75.98%-147.68K
60.89%-25.84K
71.81%-50.12K
87.50%-24.14K
73.25%-47.58K
28.73%-614.93K
39.50%-66.08K
19.46%-177.79K
-5.81%-193.16K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022(Q2)May 31, 2022(Q1)Feb 28, 2022(FY)Nov 30, 2021(Q4)Nov 30, 2021(Q3)Aug 31, 2021(Q2)May 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -69.71%-80.75K75.98%-147.68K60.89%-25.84K71.81%-50.12K87.50%-24.14K73.25%-47.58K28.73%-614.93K39.50%-66.08K19.46%-177.79K-5.81%-193.16K
Net income from continuing operations 2.09%-132.63K55.89%-480.28K49.91%-201.45K60.74%-94.73K83.00%-48.63K15.00%-135.46K12.04%-1.09M-21,214.04%-402.2K24.83%-241.28K30.84%-286.09K
Operating gains losses ---7.24K---104.8K---18.25K--0------------------------
Depreciation and amortization --0-49.19%8.29K-29.92%2.27K-87.03%563-61.39%2.73K63.35%2.73K30.83%16.33K199.35%3.25K-52.78%4.34K543.13%7.07K
Asset impairment expenditure ----155.26%129.48K------------------50.72K------------
Remuneration paid in stock -88.56%1.77K-76.27%47.47K-83.60%4.17K-92.38%7.82K-71.80%19.97K1,245.01%15.51K1,188.75%200.03K1,642.88%25.45K5,503.60%102.6K1,687.63%70.83K
Other non cashItems --------------------------46K------------
Change In working capital -17.65%57.36K56.69%252.15K-72.51%57.93K183.36%36.23K487.74%88.34K426.30%69.65K-59.08%160.93K517.53%210.7K-157.23%-43.46K-93.35%15.03K
-Change in receivables -460.91%-3.83K104.89%5.32K100.41%559-154.84%-5.31K-85.18%10.75K98.79%-683-56.74%-108.93K-78.49%-134.83K47.49%9.68K657.35%72.56K
-Change in prepaid assets 92.85%-988-100.72%-5350.20%6.29K5.58%6.34K118.51%1.14K-509.15%-13.82K-56.26%7.41K-51.43%4.19K-46.76%6.01K-751.24%-6.16K
-Change in payables and accrued expense -26.11%62.18K-5.93%246.88K-85.03%51.09K159.50%35.19K248.83%76.45K166.18%84.15K-41.13%262.45K1,973.80%341.35K-201.81%-59.14K-121.76%-51.37K
Cash from discontinued investing activities
Operating cash flow -69.71%-80.75K75.98%-147.68K60.89%-25.84K71.81%-50.12K87.50%-24.14K73.25%-47.58K28.73%-614.93K39.50%-66.08K19.46%-177.79K-5.81%-193.16K
Investing cash flow
Cash flow from continuing investing activities 7.24K8.98K8.34K000
Net PPE purchase and sale --7.24K--8.98K--8.34K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow --7.24K--8.98K--8.34K----------0--0--0--------
Financing cash flow
Cash flow from continuing financing activities 25.90%75.54K-75.19%154.84K-64.72%8.96K-26.41%40.96K195.22%44.92K-88.63%60K32.48%624.08K3,399.48%25.41K-57.32%55.66K-95.54%15.21K
Net issuance payments of debt -5.57%75.54K283.16%174.84K-64.72%8.96K717.50%40.96K195.22%44.92K--80K-64.81%45.63K--25.41K--5.01K--15.21K
Net common stock issuance ------0--0--0--------82.91%624.5K--0---125.5K-44.35%190K
Net other financing activities ----56.57%-20K--0--0--037.89%-20K---46.05K--0--176.15K---190K
Cash from discontinued financing activities
Financing cash flow 25.90%75.54K-75.19%154.84K-64.72%8.96K-26.41%40.96K195.22%44.92K-88.63%60K32.48%624.08K3,399.48%25.41K-57.32%55.66K-95.54%15.21K
Net cash flow
Beginning cash position 207.87%8.37K54.11%-7.76K-66.07%16.91K-83.59%25.44K-98.67%4.66K---7.76K-104.51%-16.91K-37.43%49.82K-15.47%155.05K3,053.45%349.91K
Current changes in cash -83.57%2.04K76.27%16.13K79.01%-8.54K93.01%-8.53K111.68%20.78K-96.45%12.42K102.34%9.15K63.02%-40.67K-35.22%-122.13K-212.02%-177.95K
End cash Position 123.22%10.41K207.87%8.37K207.87%8.37K-66.07%16.91K-83.59%25.44K-98.67%4.66K54.11%-7.76K54.11%-7.76K-37.43%49.82K-15.47%155.05K
Free cash from -69.71%-80.75K75.98%-147.68K60.89%-25.84K71.81%-50.12K87.50%-24.14K73.25%-47.58K28.73%-614.93K39.50%-66.08K19.46%-177.79K-5.81%-193.16K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data